Mario A Eisenberger

Mario A Eisenberger

UNVERIFIED PROFILE

Are you Mario A Eisenberger?   Register this Author

Register author
Mario A Eisenberger

Mario A Eisenberger

Publications by authors named "Mario A Eisenberger"

Are you Mario A Eisenberger?   Register this Author

100Publications

3124Reads

39Profile Views

Progress in the Systemic Management of Advanced Prostate Cancer: The Hormone-Sensitive Paradigm.

Authors:
Channing J Paller Mario A Eisenberger

J Clin Oncol 2019 Nov 4;37(32):2957-2960. Epub 2019 Sep 4.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.19.01863DOI Listing
November 2019

Differential Response to Olaparib Treatment Among Men with Metastatic Castration-resistant Prostate Cancer Harboring BRCA1 or BRCA2 Versus ATM Mutations.

Authors:
Catherine H Marshall Alexandra O Sokolova Andrea L McNatty Heather H Cheng Mario A Eisenberger Alan H Bryce Michael T Schweizer Emmanuel S Antonarakis

Eur Urol 2019 Oct 21;76(4):452-458. Epub 2019 Feb 21.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2019.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703974PMC
October 2019

A pilot study of prostate-specific membrane antigen (PSMA) dynamics in men undergoing treatment for advanced prostate cancer.

Authors:
Channing J Paller Danilo Piana James R Eshleman Stacy Riel Samuel R Denmeade Pedro Isaacsson Velho Steven P Rowe Martin G Pomper Emmanuel S Antonarakis Jun Luo Mario A Eisenberger

Prostate 2019 Oct 30;79(14):1597-1603. Epub 2019 Jul 30.

Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.23883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818502PMC
October 2019

Genomic and clinical characterization of pulmonary-only metastatic prostate cancer: A unique molecular subtype.

Authors:
Eugene Shenderov Pedro Isaacsson Velho Anas H Awan Hao Wang Nooshin Mirkheshti Tamara L Lotan Michael A Carducci Drew M Pardoll Mario A Eisenberger Emmanuel S Antonarakis

Prostate 2019 Sep 7;79(13):1572-1579. Epub 2019 Aug 7.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.23881DOI Listing
September 2019

Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.

Authors:
Pedro Isaacsson Velho Fahad Qazi Sayeedul Hassan Michael A Carducci Samuel R Denmeade Mark C Markowski Daniel L Thorek Theodore L DeWeese Daniel Y Song Phuoc T Tran Mario A Eisenberger Emmanuel S Antonarakis

Eur Urol 2019 Aug 4;76(2):170-176. Epub 2018 Oct 4.

Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA; Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838183072
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2018.09.040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447475PMC
August 2019

Molecular Characterization and Clinical Outcomes of Primary Gleason Pattern 5 Prostate Cancer After Radical Prostatectomy.

Authors:
Pedro Isaacsson Velho David Lim Hao Wang Jong Chul Park Harsimar B Kaur Fawaz Almutairi Michael A Carducci Samuel R Denmeade Mark C Markowski William B Isaacs Emmanuel S Antonarakis Colin C Pritchard Mario A Eisenberger Tamara L Lotan

JCO Precis Oncol 2019 26;3. Epub 2019 Jul 26.

Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/PO.19.00081DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812513PMC
July 2019

Wnt-pathway Activating Mutations Are Associated with Resistance to First-line Abiraterone and Enzalutamide in Castration-resistant Prostate Cancer.

Authors:
Pedro Isaacsson Velho Wei Fu Hao Wang Nooshin Mirkheshti Fahad Qazi Fabiola A S Lima Farah Shaukat Michael A Carducci Samuel R Denmeade Channing J Paller Mark C Markowski Catherine H Marshall Mario A Eisenberger Emmanuel S Antonarakis

Eur Urol 2019 Jun 5. Epub 2019 Jun 5.

Johns Hopkins Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA; Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2019.05.032DOI Listing
June 2019

Genetic Alterations Detected in Cell-Free DNA Are Associated With Enzalutamide and Abiraterone Resistance in Castration-Resistant Prostate Cancer.

Authors:
Samantha Torquato Aparna Pallavajjala Alexa Goldstein Patricia Valda Toro John L Silberstein Justin Lee Mary Nakazawa Ian Waters David Chu Daniel Shinn Taylor Groginski Robert M Hughes Brian W Simons Hamda Khan Zhaoyong Feng Michael A Carducci Channing J Paller Samuel R Denmeade Bruce Kressel Mario A Eisenberger Emmanuel S Antonarakis Bruce J Trock Ben H Park Paula J Hurley

JCO Precis Oncol 2019 3;3. Epub 2019 Apr 3.

Johns Hopkins School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/PO.18.00227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532665PMC
April 2019

Expression of AR-V7 and ARv in Circulating Tumor Cells Correlates with Outcomes to Taxane Therapy in Men with Metastatic Prostate Cancer Treated in TAXYNERGY.

Authors:
Scott T Tagawa Emmanuel S Antonarakis Ada Gjyrezi Giuseppe Galletti Seaho Kim Daniel Worroll John Stewart Atef Zaher Ted P Szatrowski Karla V Ballman Katsuhiro Kita Shinsuke Tasaki Yang Bai Luigi Portella Brian J Kirby Fred Saad Mario A Eisenberger David M Nanus Paraskevi Giannakakou

Clin Cancer Res 2019 Mar 9;25(6):1880-1888. Epub 2018 Oct 9.

Weill Cornell Medicine/Meyer Cancer Center, New York, New York.

View Article

Download full-text PDF

 Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-0320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6432911PMC
March 2019

Overall Survival of Black and White Men With Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel.

Authors:
Susan Halabi Sandipan Dutta Catherine M Tangen Mark Rosenthal Daniel P Petrylak Ian M Thompson Kim N Chi John C Araujo Christopher Logothetis David I Quinn Karim Fizazi Michael J Morris Mario A Eisenberger Daniel J George Johann S De Bono Celestia S Higano Ian F Tannock Eric J Small William Kevin Kelly

J Clin Oncol 2019 02 21;37(5):403-410. Epub 2018 Dec 21.

15 Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

 Source
http://ascopubs.org/doi/10.1200/JCO.18.01279
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01279DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804881PMC
February 2019

Androgen Receptor Targeted Treatments of Prostate Cancer: 35 Years of Progress with Antiandrogens.

Authors:
E David Crawford Paul F Schellhammer David G McLeod Judd W Moul Celestia S Higano Neal Shore Louis Denis Peter Iversen Mario A Eisenberger Fernand Labrie

J Urol 2018 11 3;200(5):956-966. Epub 2018 May 3.

Endoceutics, Quebec City, Quebec, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.juro.2018.04.083DOI Listing
November 2018

There Is Now Compelling Evidence to Further Evaluate Lower Doses of Abiraterone Acetate in Men With Metastatic Prostate Cancer: It Should Be Safer, May Be as Effective and Less Expensive.

Authors:
Pedro Isaacsson Velho Mario A Eisenberger

J Clin Oncol 2018 10 6;36(30):3059-3060. Epub 2018 Sep 6.

Pedro Isaacsson Velho and Mario A. Eisenberger, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://ascopubs.org/doi/10.1200/JCO.2018.79.3166
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.79.3166DOI Listing
October 2018

Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).

Authors:
Niven Mehra David Dolling Semini Sumanasuriya Rossitza Christova Lorna Pope Suzanne Carreira George Seed Wei Yuan Jane Goodall Emma Hall Penny Flohr Gunther Boysen Diletta Bianchini Oliver Sartor Mario A Eisenberger Karim Fizazi Stephane Oudard Mustapha Chadjaa Sandrine Macé Johann S de Bono

Eur Urol 2018 09 28;74(3):283-291. Epub 2018 Feb 28.

Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2018.02.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6090941PMC
September 2018

Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer.

Authors:
Karim Boudadi Daniel L Suzman Valsamo Anagnostou Wei Fu Brandon Luber Hao Wang Noushin Niknafs James R White John L Silberstein Rana Sullivan Donna Dowling Rana Harb Thomas R Nirschl Brendan A Veeneman Scott A Tomlins Yipeng Wang Adam Jendrisak Ryon P Graf Ryan Dittamore Michael A Carducci Mario A Eisenberger Michael C Haffner Alan K Meeker James R Eshleman Jun Luo Victor E Velculescu Charles G Drake Emmanuel S Antonarakis

Oncotarget 2018 Jun 19;9(47):28561-28571. Epub 2018 Jun 19.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.25564DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033362PMC
June 2018

Point: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for Chemotherapy.

Authors:
Pedro Isaacsson Velho Mario A Eisenberger

Oncology (Williston Park) 2018 05;32(5):223-6

View Article

Download full-text PDF

 Source
May 2018

Reply to M. Horiguchi et al.

Authors:
Mario A Eisenberger Wenping Zhang Zhenming Shun Johann de Bono

J Clin Oncol 2018 03 26;36(8):826-827. Epub 2018 Jan 26.

Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Wenping Zhang, Sanofi, Bridgewater, NJ; Zhenming Shun, Sanofi, Cambridge, MA; and Johann de Bono, Royal Marsden National Health Service Foundation Trust/The Institute of Cancer Research, Sutton, United Kingdom.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2017.76.3748DOI Listing
March 2018

Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical Trial.

Authors:
Channing J Paller Xian C Zhou Elisabeth I Heath Mary-Ellen Taplin Tina Mayer Mark N Stein Glenn J Bubley Roberto Pili Tamaro Hudson Radhika Kakarla Muneer M Abbas Nicole M Anders Donna Dowling Serina King Ashley B Bruns William D Wagner Charles G Drake Emmanuel S Antonarakis Mario A Eisenberger Samuel R Denmeade Michelle A Rudek Gary L Rosner Michael A Carducci

Clin Cancer Res 2018 01 7;24(2):306-315. Epub 2017 Nov 7.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1100DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771949PMC
January 2018

Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.

Authors:
Benjamin A Teply Hao Wang Brandon Luber Rana Sullivan Irina Rifkind Ashley Bruns Avery Spitz Morgan DeCarli Victoria Sinibaldi Caroline F Pratz Changxue Lu John L Silberstein Jun Luo Michael T Schweizer Charles G Drake Michael A Carducci Channing J Paller Emmanuel S Antonarakis Mario A Eisenberger Samuel R Denmeade

Lancet Oncol 2018 01 14;19(1):76-86. Epub 2017 Dec 14.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(17)30906-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875180PMC
January 2018

MSH2 Loss in Primary Prostate Cancer.

Authors:
Liana B Guedes Emmanuel S Antonarakis Michael T Schweizer Nooshin Mirkheshti Fawaz Almutairi Jong Chul Park Stephanie Glavaris Jessica Hicks Mario A Eisenberger Angelo M De Marzo Jonathan I Epstein William B Isaacs James R Eshleman Colin C Pritchard Tamara L Lotan

Clin Cancer Res 2017 Nov 8;23(22):6863-6874. Epub 2017 Aug 8.

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-0955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690834PMC
November 2017

Randomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naïve, Metastatic, Castration-Resistant Prostate Cancer.

Authors:
Emmanuel S Antonarakis Scott T Tagawa Giuseppe Galletti Daniel Worroll Karla Ballman Marie Vanhuyse Guru Sonpavde Scott North Costantine Albany Che-Kai Tsao John Stewart Atef Zaher Ted Szatrowski Wei Zhou Ada Gjyrezi Shinsuke Tasaki Luigi Portella Yang Bai Timothy B Lannin Shalu Suri Conor N Gruber Erica D Pratt Brian J Kirby Mario A Eisenberger David M Nanus Fred Saad Paraskevi Giannakakou

J Clin Oncol 2017 Oct 20;35(28):3181-3188. Epub 2017 Jun 20.

Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center; Che-Kai Tsao, Mount Sinai Medical Center, New York; Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University, Ithaca, NY; Marie Vanhuyse, Medical Oncology, Montréal General Hospital; Fred Saad, University of Montreal Hospital Center, Montreal; John Stewart, Atef Zaher, and Wei Zhou, Sanofi, Laval, Quebec, Canada; Guru Sonpavde, University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; Scott North, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada; Costantine Albany, Indiana University School of Medicine, Indianapolis, IN; and Ted Szatrowski, Sanofi, Bridgewater, NJ.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2017.72.4138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791829PMC
October 2017

Clinical Utility of CLIA-Grade AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer.

Authors:
Mark C Markowski John L Silberstein James R Eshleman Mario A Eisenberger Jun Luo Emmanuel S Antonarakis

JCO Precis Oncol 2017 30;2017. Epub 2017 Oct 30.

Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697780PMC
http://dx.doi.org/10.1200/PO.17.00127DOI Listing
October 2017

Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide.

Authors:
Emmanuel S Antonarakis Changxue Lu Brandon Luber Hao Wang Yan Chen Yezi Zhu John L Silberstein Maritza N Taylor Benjamin L Maughan Samuel R Denmeade Kenneth J Pienta Channing J Paller Michael A Carducci Mario A Eisenberger Jun Luo

J Clin Oncol 2017 Jul 6;35(19):2149-2156. Epub 2017 Apr 6.

All authors: Johns Hopkins University School of Medicine, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2016.70.1961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493048PMC
July 2017

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.

Authors:
Rong Na S Lilly Zheng Misop Han Hongjie Yu Deke Jiang Sameep Shah Charles M Ewing Liti Zhang Kristian Novakovic Jacqueline Petkewicz Kamalakar Gulukota Donald L Helseth Margo Quinn Elizabeth Humphries Kathleen E Wiley Sarah D Isaacs Yishuo Wu Xu Liu Ning Zhang Chi-Hsiung Wang Janardan Khandekar Peter J Hulick Daniel H Shevrin Kathleen A Cooney Zhoujun Shen Alan W Partin H Ballentine Carter Michael A Carducci Mario A Eisenberger Sam R Denmeade Michael McGuire Patrick C Walsh Brian T Helfand Charles B Brendler Qiang Ding Jianfeng Xu William B Isaacs

Eur Urol 2017 05 15;71(5):740-747. Epub 2016 Dec 15.

Department of Urology and the James Buchanan Brady Urologic Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838163088
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2016.11.033DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535082PMC
May 2017

Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer.

Authors:
Benjamin A Teply Sushant Kachhap Mario A Eisenberger Samuel R Denmeade

Eur Urol 2017 03 29;71(3):499. Epub 2016 Sep 29.

Department of Oncology, Johns Hopkins Medicine, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2016.09.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808412PMC
March 2017

Detection fidelity of AR mutations in plasma derived cell-free DNA.

Authors:
Alexa Goldstein Patricia Valda Toro Justin Lee John L Silberstein Mary Nakazawa Ian Waters Karen Cravero David Chu Rory L Cochran Minsoo Kim Daniel Shinn Samantha Torquato Robert M Hughes Aparna Pallavajjala Michael A Carducci Channing J Paller Samuel R Denmeade Bruce Kressel Bruce J Trock Mario A Eisenberger Emmanuel S Antonarakis Ben H Park Paula J Hurley

Oncotarget 2017 Feb;8(9):15651-15662

The James Buchanan Brady Urological Institute, Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.14926DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362513PMC
February 2017

A Potential Predictive Role for Prostate-specific Antigen Changes at 4 Weeks?

Authors:
Benjamin L Maughan Mario A Eisenberger

Eur Urol 2016 11 5;70(5):732-733. Epub 2016 Apr 5.

Genitourinary Oncology Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2016.03.032DOI Listing
November 2016

Metformin Use and Outcome of Sunitinib Treatment in Patients With Diabetes and Metastatic Renal Cell Carcinoma.

Authors:
Daniel Keizman Maya Ish-Shalom Avishay Sella Maya Gottfried Natalie Maimon Avivit Peer Hans Hammers Mario A Eisenberger Victoria Sinibaldi Victoria Neiman Eli Rosenbaum David Sarid Wilmosh Mermershtain Keren Rouvinov Raanan Berger Michael A Carducci

Clin Genitourin Cancer 2016 10 27;14(5):420-425. Epub 2016 Apr 27.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clgc.2016.04.012DOI Listing
October 2016

Outcome of Patients With Metastatic Chromophobe Renal Cell Carcinoma Treated With Sunitinib.

Authors:
Daniel Keizman David Sarid Jae L Lee Avishay Sella Maya Gottfried Hans Hammers Mario A Eisenberger Michael A Carducci Victoria Sinibaldi Victoria Neiman Eli Rosenbaum Avivit Peer Avivit Neumann Wilmosh Mermershtain Keren Rouvinov Raanan Berger Ibrahim Yildiz

Oncologist 2016 10 5;21(10):1212-1217. Epub 2016 Jul 5.

Acibadem University Atakent Hospital, Istanbul, Turkey.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2015-0428DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5061527PMC
October 2016

Bipolar Androgen Therapy for Men With Androgen Ablation Naïve Prostate Cancer: Results From the Phase II BATMAN Study.

Authors:
Michael T Schweizer Hao Wang Brandon Luber Rosa Nadal Avery Spitz D Marc Rosen Haiyi Cao Emmanuel S Antonarakis Mario A Eisenberger Michael A Carducci Channing Paller Samuel R Denmeade

Prostate 2016 09 24;76(13):1218-26. Epub 2016 Jun 24.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.23209DOI Listing
September 2016

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer.

Authors:
Susan Halabi William Kevin Kelly Hua Ma Haojin Zhou Nicole C Solomon Karim Fizazi Catherine M Tangen Mark Rosenthal Daniel P Petrylak Maha Hussain Nicholas J Vogelzang Ian M Thompson Kim N Chi Johann de Bono Andrew J Armstrong Mario A Eisenberger Abderrahim Fandi Shaoyi Li John C Araujo Christopher J Logothetis David I Quinn Michael J Morris Celestia S Higano Ian F Tannock Eric J Small

J Clin Oncol 2016 05 7;34(14):1652-9. Epub 2016 Mar 7.

Susan Halabi, Hua Ma, Nicole C. Solomon, and Andrew J. Armstrong, Duke University, Durham, NC; William Kevin Kelly, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Haojin Zhou, Merck, Beijing, China; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Catherine M. Tangen, Southwest Oncology Group Statistical Center; Mark Rosenthal, Royal Melbourne Hospital, Melbourne, Victoria, Australia; Daniel P. Petrylak, Yale Cancer Center, New Haven, CT; Maha Hussain, University of Michigan, Ann Arbor, MI; Nicholas J. Vogelzang, US Oncology, Las Vegas, NV; Ian M. Thompson, University of Texas at San Antonio, San Antonio; John C. Araujo and Christopher J. Logothetis, The University of Texas MD Anderson Cancer Center, Houston, TX; Kim N. Chi, British Columbia Cancer Agency-Vancouver Cancer Centre, Vancouver, British Columbia; Ian F. Tannock, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada; Johann de Bono, Institute for Cancer Research, Royal Marsden Hospital, Sutton, Surrey, United Kingdom; Mario A. Eisenberger, Johns Hopkins University-School of Medicine, Oncology Center, Baltimore, MD; Abderrahim Fandi and Shaoyi Li, Celgene Corporation, Summit, NJ; David I. Quinn, University of Southern California Norris Cancer Center, Los Angeles; Eric J. Small, University of California San Francisco, San Francisco, CA; Celestia S. Higano, University of Washington, Seattle, WA; and Michael J. Morris, Memorial Sloan-Kettering Cancer Center New York, NY.

View Article

Download full-text PDF

 Source
http://ascopubs.org/doi/10.1200/JCO.2015.65.7270
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.65.7270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872320PMC
May 2016

A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.

Authors:
Jong Chul Park Nilay M Gandhi Michael A Carducci Mario A Eisenberger Alexander S Baras George J Netto Jen-Jane Liu Charles G Drake Mark P Schoenberg Trinity J Bivalacqua Noah M Hahn

J Urol 2016 Apr 18;195(4 Pt 1):880-5. Epub 2015 Nov 18.

Department of Oncology, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland; Department of Urology, Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.juro.2015.11.024DOI Listing
April 2016

Prognostic factors for clinical outcomes in patients with metastatic castration resistant prostate cancer treated with sequential novel androgen receptor-directed therapies.

Authors:
Rosa Nadal Hua-Ling Tsai Victoria J Sinibaldi Channing J Paller Emmanuel S Antonarakis Sammuel R Denmeade Michael A Carducci Mario A Eisenberger

Prostate 2016 Apr 22;76(5):512-20. Epub 2015 Dec 22.

Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.23141DOI Listing
April 2016

Androgen Receptor Modulation Optimized for Response (ARMOR) Phase I and II Studies: Galeterone for the Treatment of Castration-Resistant Prostate Cancer.

Authors:
Bruce Montgomery Mario A Eisenberger Matthew B Rettig Franklin Chu Roberto Pili Joseph J Stephenson Nicholas J Vogelzang Alan J Koletsky Luke T Nordquist William J Edenfield Khalid Mamlouk Karen J Ferrante Mary-Ellen Taplin

Clin Cancer Res 2016 Mar 2;22(6):1356-63. Epub 2015 Nov 2.

Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1432DOI Listing
March 2016

Is there a "Trial Effect" on Outcome of Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib?

Authors:
Daniel Keizman Keren Rouvinov Avishay Sella Maya Gottfried Natalie Maimon Jenny J Kim Mario A Eisenberger Victoria Sinibaldi Avivit Peer Michael A Carducci Wilmosh Mermershtain Raya Leibowitz-Amit Rony Weitzen Raanan Berger

Cancer Res Treat 2016 Jan 5;48(1):281-7. Epub 2015 Mar 5.

Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar Saba, Israel.

View Article

Download full-text PDF

 Source
http://e-crt.org/journal/view.php?doi=10.4143/crt.2014.289
Publisher Site
http://dx.doi.org/10.4143/crt.2014.289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720089PMC
January 2016

Comparison of Prostate-Specific Membrane Antigen-Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer.

Authors:
Steven P Rowe Katarzyna J Macura Anthony Ciarallo Esther Mena Amanda Blackford Rosa Nadal Emmanuel S Antonarakis Mario A Eisenberger Michael A Carducci Ashley E Ross Philip W Kantoff Daniel P Holt Robert F Dannals Ronnie C Mease Martin G Pomper Steve Y Cho

J Nucl Med 2016 Jan 22;57(1):46-53. Epub 2015 Oct 22.

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2967/jnumed.115.163782DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730886PMC
January 2016

Intermittent Androgen Deprivation in Prostate Cancer: Are We Ready to Quit?

Authors:
Jong Chul Park Mario A Eisenberger

J Clin Oncol 2016 Jan 30;34(3):211-4. Epub 2015 Nov 30.

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2015.64.1019DOI Listing
January 2016

Advances in the Treatment of Metastatic Prostate Cancer.

Authors:
Jong Chul Park Mario A Eisenberger

Mayo Clin Proc 2015 Dec;90(12):1719-33

Genito-Urinary Oncology Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.mayocp.2015.10.010DOI Listing
December 2015

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination.

Authors:
Channing J Paller Michelle A Rudek Xian C Zhou William D Wagner Tamaro S Hudson Nicole Anders Hans J Hammers Donna Dowling Serina King Emmanuel S Antonarakis Charles G Drake Mario A Eisenberger Samuel R Denmeade Gary L Rosner Michael A Carducci

Prostate 2015 Oct 27;75(14):1518-25. Epub 2015 May 27.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.23024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537354PMC
October 2015

Sarcomatoid Carcinoma of the Prostate: Retrospective Review of a Case Series From the Johns Hopkins Hospital.

Authors:
Mark C Markowski Mario A Eisenberger Marianna Zahurak Jonathan I Epstein Channing J Paller

Urology 2015 Sep 28;86(3):539-43. Epub 2015 Jun 28.

Division of Medical Oncology, Sidney Kimmel Cancer Center, The Johns Hopkins University, Baltimore, MD. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.urology.2015.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569516PMC
September 2015

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer.

Authors:
Zsolt Szabo Esther Mena Steven P Rowe Donika Plyku Rosa Nidal Mario A Eisenberger Emmanuel S Antonarakis Hong Fan Robert F Dannals Ying Chen Ronnie C Mease Melin Vranesic Akrita Bhatnagar George Sgouros Steve Y Cho Martin G Pomper

Mol Imaging Biol 2015 Aug;17(4):565-74

The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Cancer Research Bldg. 2, Room 492, 1550 Orleans St, Baltimore, MD, 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s11307-015-0850-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531836PMC
August 2015

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.

Authors:
Emmanuel S Antonarakis Changxue Lu Brandon Luber Hao Wang Yan Chen Mary Nakazawa Rosa Nadal Channing J Paller Samuel R Denmeade Michael A Carducci Mario A Eisenberger Jun Luo

JAMA Oncol 2015 Aug;1(5):582-91

Department of Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1001/jamaoncol.2015.1341DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537351PMC
August 2015

Cancer-Related Fatigue, Version 2.2015.

Authors:
Ann M Berger Kathi Mooney Amy Alvarez-Perez William S Breitbart Kristen M Carpenter David Cella Charles Cleeland Efrat Dotan Mario A Eisenberger Carmen P Escalante Paul B Jacobsen Catherine Jankowski Thomas LeBlanc Jennifer A Ligibel Elizabeth Trice Loggers Belinda Mandrell Barbara A Murphy Oxana Palesh William F Pirl Steven C Plaxe Michelle B Riba Hope S Rugo Carolina Salvador Lynne I Wagner Nina D Wagner-Johnston Finly J Zachariah Mary Anne Bergman Courtney Smith

J Natl Compr Canc Netw 2015 Aug;13(8):1012-39

View Article

Download full-text PDF

 Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5499710PMC
http://dx.doi.org/10.6004/jnccn.2015.0122DOI Listing
August 2015

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.

Authors:
Michael T Schweizer Emmanuel S Antonarakis Hao Wang A Seun Ajiboye Avery Spitz Haiyi Cao Jun Luo Michael C Haffner Srinivasan Yegnasubramanian Michael A Carducci Mario A Eisenberger John T Isaacs Samuel R Denmeade

Sci Transl Med 2015 Jan;7(269):269ra2

The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1126/scitranslmed.3010563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507510PMC
January 2015

Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel.

Authors:
Philipp Nuhn Ajay M Vaghasia Jatinder Goyal Xian C Zhou Michael A Carducci Mario A Eisenberger Emmanuel S Antonarakis

BJU Int 2014 Dec 14;114(6b):E11-E17. Epub 2014 Feb 14.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bju.12531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004702PMC
December 2014

Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.

Authors:
Rosa Nadal Zhe Zhang Hibba Rahman Michael T Schweizer Samuel R Denmeade Channing J Paller Michael A Carducci Mario A Eisenberger Emmanuel S Antonarakis

Prostate 2014 Nov 31;74(15):1560-8. Epub 2014 Aug 31.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.22874DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176523PMC
November 2014

The influence of prior abiraterone treatment on the clinical activity of docetaxel in men with metastatic castration-resistant prostate cancer.

Authors:
Michael T Schweizer Xian C Zhou Hao Wang Sunakshi Bassi Michael A Carducci Mario A Eisenberger Emmanuel S Antonarakis

Eur Urol 2014 Oct 24;66(4):646-52. Epub 2014 Jan 24.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2014.01.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110192PMC
October 2014

A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma.

Authors:
Maha Hussain Stephanie Daignault Neeraj Agarwal Petros D Grivas Arlene O Siefker-Radtke Igor Puzanov Gary R MacVicar Ellis Glenn Levine Sandy Srinivas Przemyslaw Twardowski Mario A Eisenberger David I Quinn Ulka N Vaishampayan Evan Y Yu Scott Dawsey Kathleen C Day Mark L Day Mahmoud Al-Hawary David C Smith

Cancer 2014 Sep 6;120(17):2684-93. Epub 2014 May 6.

University of Michigan, Ann Arbor, Michigan.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.28767DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142676PMC
September 2014

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.

Authors:
Emmanuel S Antonarakis Changxue Lu Hao Wang Brandon Luber Mary Nakazawa Jeffrey C Roeser Yan Chen Tabrez A Mohammad Yidong Chen Helen L Fedor Tamara L Lotan Qizhi Zheng Angelo M De Marzo John T Isaacs William B Isaacs Rosa Nadal Channing J Paller Samuel R Denmeade Michael A Carducci Mario A Eisenberger Jun Luo

N Engl J Med 2014 Sep 3;371(11):1028-38. Epub 2014 Sep 3.

From the Departments of Oncology (E.S.A., H.W., B.L., J.T.I., R.N., C.J.P., S.R.D., M.A.C., M.A.E.), Pathology (H.L.F., T.L.L., Q.Z., A.M.D.M.), and Urology (C.L., M.N., J.C.R., Yan Chen, W.B.I., J.L.), Johns Hopkins University School of Medicine, Baltimore; and Greehey Children's Cancer Research Institute (T.A.M., Yidong Chen) and the Department of Epidemiology and Biostatistics (Yidong Chen), University of Texas Health Science Center at San Antonio, San Antonio.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1315815DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201502PMC
September 2014

Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: data from the TAX327 study.

Authors:
Robert J van Soest Ellen S de Morrée Liji Shen Ian F Tannock Mario A Eisenberger Ronald de Wit

Eur Urol 2014 Aug 11;66(2):330-6. Epub 2013 Aug 11.

Department of Medical Oncology, Erasmus University Medical Center and Erasmus MC Cancer Institute, Rotterdam, The Netherlands.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2013.08.007DOI Listing
August 2014

Maximal testosterone suppression in prostate cancer--free vs total testosterone.

Authors:
Kyle O Rove E David Crawford Massimo Perachino Juan Morote Laurence Klotz Paul H Lange Gerald L Andriole Alvin M Matsumoto Samir S Taneja Mario A Eisenberger Leonardo O Reis

Urology 2014 Jun 6;83(6):1217-22. Epub 2014 Apr 6.

University of Campinas, School of Medical Sciences, UNICAMP, Brazil.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.urology.2014.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332796PMC
June 2014

Determining the optimal treatment for metastatic castration-resistant prostate cancer: age should not be a factor.

Authors:
Daniel L Suzman Mario A Eisenberger

Eur Urol 2014 May 16;65(5):884-6. Epub 2013 Oct 16.

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA. Electronic address:

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838130107
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2013.10.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4090698PMC
May 2014

Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxel.

Authors:
Avivit Peer Maya Gottfried Victoria Sinibaldi Michael A Carducci Mario A Eisenberger Avishay Sella Raya Leibowitz-Amit Raanan Berger Daniel Keizman

Prostate 2014 Apr 11;74(4):433-40. Epub 2013 Dec 11.

Department of Oncology, Rambam Medical Center, Haifa, Israel.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/pros.22765
Publisher Site
http://dx.doi.org/10.1002/pros.22765DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696030PMC
April 2014

Tolerability and efficacy of docetaxel in older men with metastatic castrate-resistant prostate cancer (mCRPC) in the TAX 327 trial.

Authors:
Anne M Horgan Bostjan Seruga Greg R Pond Shabbir M Alibhai Eitan Amir Ronald De Wit Mario A Eisenberger Ian F Tannock

J Geriatr Oncol 2014 Apr 2;5(2):119-26. Epub 2014 Jan 2.

Department of Medical Oncology, Princess Margaret Hospital, University Health Network and the University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.jgo.2013.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352315PMC
April 2014

Small cell carcinoma of the prostate.

Authors:
Rosa Nadal Michael Schweizer Oleksandr N Kryvenko Jonathan I Epstein Mario A Eisenberger

Nat Rev Urol 2014 Apr 18;11(4):213-9. Epub 2014 Feb 18.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, 1650 Orleans Street, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/nrurol.2014.21DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339095PMC
April 2014

The prognostic importance of metastatic site in men with metastatic castration-resistant prostate cancer.

Authors:
Gregory R Pond Guru Sonpavde Ronald de Wit Mario A Eisenberger Ian F Tannock Andrew J Armstrong

Eur Urol 2014 Jan 5;65(1):3-6. Epub 2013 Oct 5.

Department of Oncology, McMaster University and Escarpment Cancer Research Institute, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838130101
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2013.09.024DOI Listing
January 2014

Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinib.

Authors:
Daniel Keizman Maya Gottfried Maya Ish-Shalom Natalie Maimon Avivit Peer Avivit Neumann Hans Hammers Mario A Eisenberger Victoria Sinibaldi Roberto Pili Henry Hayat Svetlana Kovel Avishay Sella Ben Boursi Rony Weitzen Wilmosh Mermershtain Keren Rouvinov Raanan Berger Michael A Carducci

Oncologist 2014 Jan 5;19(1):51-60. Epub 2013 Dec 5.

Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center and the Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel; Department of Oncology, Rambam Medical Center, Haifa, Israel; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA; Roswell Park Cancer Institute, Buffalo, New York, USA; Department of Oncology, Wolfson Medical Center, Holon, Israel; Department of Oncology, Asaf Harofe Medical Center, Zerifin, Israel; Department of Oncology, Sheba Medical Center, Tel Hashomer, Israel; Department of Oncology, Soroka University Medical Center, Beer-sheva, Israel.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2012-0335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903056PMC
January 2014

Management of patients with biochemical recurrence after local therapy for prostate cancer.

Authors:
Channing J Paller Emmanuel S Antonarakis Mario A Eisenberger Michael A Carducci

Hematol Oncol Clin North Am 2013 Dec 18;27(6):1205-19, viii. Epub 2013 Sep 18.

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB1-1M59, Baltimore, MD 21287, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.hoc.2013.08.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818691PMC
December 2013

Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials.

Authors:
Michael T Schweizer Peng Huang Michael W Kattan Adam S Kibel Ronald de Wit Cora N Sternberg Jonathan I Epstein Mario A Eisenberger

Cancer 2013 Oct 13;119(20):3610-8. Epub 2013 Aug 13.

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.28270DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124610PMC
October 2013

Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram.

Authors:
Daniel Keizman Maya Gottfried Maya Ish-Shalom Natalie Maimon Avivit Peer Avivit Neumann Eli Rosenbaum Svetlana Kovel Roberto Pili Victoria Sinibaldi Michael A Carducci Hans Hammers Mario A Eisenberger Avishay Sella

Oncologist 2012 12;17(12):1508-14. Epub 2012 Sep 12.

Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Kfar-Saba, Israel.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2012-0125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528383PMC
June 2013

Phase III trials with docetaxel-based combinations for metastatic castration-resistant prostate cancer: time to learn from past experiences.

Authors:
Emmanuel S Antonarakis Mario A Eisenberger

J Clin Oncol 2013 May 8;31(14):1709-12. Epub 2013 Apr 8.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2013.48.8825DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812821PMC
May 2013

Penile cancer: Clinical Practice Guidelines in Oncology.

Authors:
Peter E Clark Philippe E Spiess Neeraj Agarwal Matthew C Biagioli Mario A Eisenberger Richard E Greenberg Harry W Herr Brant A Inman Deborah A Kuban Timothy M Kuzel Subodh M Lele Jeff Michalski Lance Pagliaro Sumanta K Pal Anthony Patterson Elizabeth R Plimack Kamal S Pohar Michael P Porter Jerome P Richie Wade J Sexton William U Shipley Eric J Small Donald L Trump Geoffrey Wile Timothy G Wilson Mary Dwyer Maria Ho

J Natl Compr Canc Netw 2013 May;11(5):594-615

View Article

Download full-text PDF

 Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042432PMC
http://dx.doi.org/10.6004/jnccn.2013.0075DOI Listing
May 2013

Bladder cancer.

Authors:
Peter E Clark Neeraj Agarwal Matthew C Biagioli Mario A Eisenberger Richard E Greenberg Harry W Herr Brant A Inman Deborah A Kuban Timothy M Kuzel Subodh M Lele Jeff Michalski Lance C Pagliaro Sumanta K Pal Anthony Patterson Elizabeth R Plimack Kamal S Pohar Michael P Porter Jerome P Richie Wade J Sexton William U Shipley Eric J Small Philippe E Spiess Donald L Trump Geoffrey Wile Timothy G Wilson Mary Dwyer Maria Ho

J Natl Compr Canc Netw 2013 Apr;11(4):446-75

Vanderbilt-Ingram Cancer Center.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.6004/jnccn.2013.0059DOI Listing
April 2013

An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy.

Authors:
Emmanuel S Antonarakis Daniel Keizman Zhe Zhang Bora Gurel Tamara L Lotan Jessica L Hicks Helen L Fedor Michael A Carducci Angelo M De Marzo Mario A Eisenberger

Cancer 2012 Dec 6;118(24):6063-71. Epub 2012 Jun 6.

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.27689DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572534PMC
December 2012

The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer.

Authors:
Jatinder Goyal Philipp Nuhn Peng Huang Prachi Tyagi Daniel Oh Michael A Carducci Mario A Eisenberger Emmanuel S Antonarakis

BJU Int 2012 Dec 15;110(11 Pt B):E575-82. Epub 2012 Jun 15.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/j.1464-410X.2012.11286.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715077PMC
December 2012

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

Authors:
Steve Y Cho Kenneth L Gage Ronnie C Mease Srinivasan Senthamizhchelvan Daniel P Holt Akimosa Jeffrey-Kwanisai Christopher J Endres Robert F Dannals George Sgouros Martin Lodge Mario A Eisenberger Ronald Rodriguez Michael A Carducci Camilo Rojas Barbara S Slusher Alan P Kozikowski Martin G Pomper

J Nucl Med 2012 Dec;53(12):1883-91

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland 21287-0014, USA.

View Article

Download full-text PDF

 Source
http://jnm.snmjournals.org/cgi/doi/10.2967/jnumed.112.104661
Publisher Site
http://dx.doi.org/10.2967/jnumed.112.104661DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742115PMC
December 2012

The experience with cytotoxic chemotherapy in metastatic castration-resistant prostate cancer.

Authors:
Mario A Eisenberger Emmanuel S Antonarakis

Urol Clin North Am 2012 Nov;39(4):573-81

Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://linkinghub.elsevier.com/retrieve/pii/S009401431200073
Publisher Site
http://dx.doi.org/10.1016/j.ucl.2012.07.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742094PMC
November 2012

Improved overall survival trends of men with newly diagnosed M1 prostate cancer: a SWOG phase III trial experience (S8494, S8894 and S9346).

Authors:
Catherine M Tangen Maha H A Hussain Celestia S Higano Mario A Eisenberger Eric J Small George Wilding Bryan J Donnelly Paul F Schelhammer E David Crawford Nicholas J Vogelzang Isaac J Powell Ian M Thompson

J Urol 2012 Oct 22;188(4):1164-9. Epub 2012 Aug 22.

Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S00225347120395
Publisher Site
http://dx.doi.org/10.1016/j.juro.2012.06.046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481164PMC
October 2012

Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapy.

Authors:
Guru Sonpavde Gregory R Pond William R Berry Ronald de Wit Andrew J Armstrong Mario A Eisenberger Ian F Tannock

Urol Oncol 2012 Sep 2;30(5):607-13. Epub 2010 Oct 2.

U.S. Oncology Research, Inc., Texas Oncology and Baylor College of Medicine, Webster, TX 77598, USA.

View Article

Download full-text PDF

 Source
http://linkinghub.elsevier.com/retrieve/pii/S107814391000176
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2010.07.002DOI Listing
September 2012

AIM1 promoter hypermethylation as a predictor of decreased risk of recurrence following radical prostatectomy.

Authors:
Eli Rosenbaum Shahnaz Begum Mariana Brait Marianna Zahurak Leonel Maldonado Leslie A Mangold Mario A Eisenberger Jonathan I Epstein Alan W Partin David Sidransky Mohammad O Hoque

Prostate 2012 Jul 29;72(10):1133-9. Epub 2011 Nov 29.

Department of Otolaryngology and Head & Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.22461DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360823PMC
July 2012

Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinoma.

Authors:
Daniel Keizman Maya Ish-Shalom Roberto Pili Hans Hammers Mario A Eisenberger Victoria Sinibaldi Ben Boursi Natalie Maimon Maya Gottfried Henry Hayat Avivit Peer Svetlana Kovel Avishay Sella Raanan Berger Michael A Carducci

Eur J Cancer 2012 May 10;48(7):1031-7. Epub 2012 Mar 10.

Genitourinary Oncology Service, Institute of Oncology, Meir Medical Center, Sackler School of Medicine, Tel Aviv University, Israel.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ejca.2012.02.050DOI Listing
May 2012

Lenalidomide modulates IL-8 and anti-prostate antibody levels in men with biochemically recurrent prostate cancer.

Authors:
Daniel J Zabransky Heath A Smith Christopher J Thoburn Marianna Zahurak Daniel Keizman Michael Carducci Mario A Eisenberger Douglas G McNeel Charles G Drake Emmanuel S Antonarakis

Prostate 2012 Apr 11;72(5):487-98. Epub 2011 Jul 11.

Johns Hopkins Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.21449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248613PMC
April 2012

Phase I trial with a combination of docetaxel and ¹⁵³Sm-lexidronam in patients with castration-resistant metastatic prostate cancer.

Authors:
Jianqing Lin Victoria J Sinibaldi Michael A Carducci Samuel Denmeade Danny Song Theodore Deweese Mario A Eisenberger

Urol Oncol 2011 Nov-Dec;29(6):670-5. Epub 2009 Dec 4.

Prostate Cancer Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.urolonc.2009.10.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483074PMC
March 2012

Contemporary experience with ketoconazole in patients with metastatic castration-resistant prostate cancer: clinical factors associated with PSA response and disease progression.

Authors:
Daniel Keizman Peng Huang Michael A Carducci Mario A Eisenberger

Prostate 2012 Mar 17;72(4):461-7. Epub 2011 Jun 17.

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/pros.21447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463372PMC
March 2012

Changes in PSA kinetics predict metastasis- free survival in men with PSA-recurrent prostate cancer treated with nonhormonal agents: combined analysis of 4 phase II trials.

Authors:
Emmanuel S Antonarakis Marianna L Zahurak Jianqing Lin Daniel Keizman Michael A Carducci Mario A Eisenberger

Cancer 2012 Mar;118(6):1533-42

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, CRB1-1M45, 1650 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.26437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252493PMC
March 2012

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial.

Authors:
Emmanuel S Antonarakis Michael A Carducci Mario A Eisenberger Samuel R Denmeade Susan F Slovin Kathy Jelaca-Maxwell Martha E Vincent Howard I Scher Michael J Morris

Cancer Chemother Pharmacol 2012 Mar 22;69(3):763-71. Epub 2011 Oct 22.

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins University School of Medicine, CRB1-1M59, 1650 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://link.springer.com/10.1007/s00280-011-1759-9
Publisher Site
http://dx.doi.org/10.1007/s00280-011-1759-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586214PMC
March 2012

Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer.

Authors:
Andrew J Armstrong Mario A Eisenberger Susan Halabi Stephane Oudard David M Nanus Daniel P Petrylak A Oliver Sartor Howard I Scher

Eur Urol 2012 Mar 12;61(3):549-59. Epub 2011 Nov 12.

Duke Cancer Institute and the Duke Prostate Center, Duke University, Durham, NC 27710, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2011.11.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445625PMC
March 2012

Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.

Authors:
Gregory R Pond Andrew J Armstrong Brian A Wood Melissa Brookes Lance Leopold William R Berry Ronald de Wit Mario A Eisenberger Ian F Tannock Guru Sonpavde

Eur Urol 2012 Feb 22;61(2):363-9. Epub 2011 Jun 22.

Department of Oncology, McMaster University and Ontario Clinical Oncology Group, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

 Source
http://linkinghub.elsevier.com/retrieve/pii/S030228381100658
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2011.06.034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483076PMC
February 2012

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer.

Authors:
Toni K Choueiri Robert W Ross Susanna Jacobus Ulka Vaishampayan Evan Y Yu David I Quinn Noah M Hahn Thomas E Hutson Guru Sonpavde Stephanie C Morrissey Geoffrey C Buckle William Y Kim Daniel P Petrylak Christopher W Ryan Mario A Eisenberger Amir Mortazavi Glenn J Bubley Mary-Ellen Taplin Jonathan E Rosenberg Philip W Kantoff

J Clin Oncol 2012 Feb 19;30(5):507-12. Epub 2011 Dec 19.

Dana-Farber Cancer Institute, Boston, MA 02215, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2011.37.7002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4104290PMC
February 2012

The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up.

Authors:
Emmanuel S Antonarakis Zhaoyong Feng Bruce J Trock Elizabeth B Humphreys Michael A Carducci Alan W Partin Patrick C Walsh Mario A Eisenberger

BJU Int 2012 Jan 20;109(1):32-9. Epub 2011 Jul 20.

Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center, Brady Urological Institute, Johns Hopkins University, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/j.1464-410X.2011.10422.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204323PMC
January 2012

Contemporary role of androgen deprivation therapy for prostate cancer.

Authors:
Vincenzo Pagliarulo Sergio Bracarda Mario A Eisenberger Nicolas Mottet Fritz H Schröder Cora N Sternberg Urs E Studer

Eur Urol 2012 Jan 19;61(1):11-25. Epub 2011 Aug 19.

Department of Urology, Aldo Moro University, Bari, Italy.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2011.08.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483081PMC
January 2012

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma.

Authors:
Daniel Keizman Maya Ish-Shalom Peng Huang Mario A Eisenberger Roberto Pili Hans Hammers Michael A Carducci

Eur J Cancer 2012 Jan 19;48(2):202-8. Epub 2011 Oct 19.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ejca.2011.09.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483077PMC
January 2012

The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen deprivation.

Authors:
Daniel Keizman Peng Huang Emmanuel S Antonarakis Victoria Sinibaldi Michael A Carducci Samuel Denmeade Jenny J Kim Janet Walczak Mario A Eisenberger

Prostate 2011 Nov 22;71(15):1608-15. Epub 2011 Mar 22.

The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/pros.21377
Publisher Site
http://dx.doi.org/10.1002/pros.21377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183345PMC
November 2011

The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapy.

Authors:
Guru Sonpavde Gregory R Pond William R Berry Ronald de Wit Mario A Eisenberger Ian F Tannock Andrew J Armstrong

Cancer 2011 Sep 1;117(17):3963-71. Epub 2011 Mar 1.

Texas Oncology and Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, Texas, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/cncr.25982DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483075PMC
September 2011

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination.

Authors:
Daniel Keizman Peng Huang Mario A Eisenberger Roberto Pili Jenny J Kim Emmanuel S Antonarakis Hans Hammers Michael A Carducci

Eur J Cancer 2011 Sep 18;47(13):1955-61. Epub 2011 May 18.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://linkinghub.elsevier.com/retrieve/pii/S095980491100284
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2011.04.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175366PMC
September 2011

Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.

Authors:
Emmanuel S Antonarakis Yongmei Chen Sally I Elsamanoudi Stephen A Brassell Mario V Da Rocha Mario A Eisenberger David G McLeod

BJU Int 2011 Aug 23;108(3):378-85. Epub 2010 Nov 23.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/j.1464-410X.2010.09878.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402027PMC
August 2011

Expanding treatment options for metastatic prostate cancer.

Authors:
Emmanuel S Antonarakis Mario A Eisenberger

N Engl J Med 2011 May;364(21):2055-8

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMe1102758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458507PMC
May 2011

A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone.

Authors:
Lee P Resta Roberto Pili Mario A Eisenberger Avery Spitz Serina King Jennifer Porter Amy Franke Ramesh Boinpally Michael A Carducci Christopher J Sweeney

Cancer Chemother Pharmacol 2011 Feb 6;67(2):431-8. Epub 2010 May 6.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, 1650 Orleans Street, CRB1-1M59, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00280-010-1328-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028086PMC
February 2011

Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer.

Authors:
Dana Rathkopf Glenn Liu Michael A Carducci Mario A Eisenberger Aseem Anand Michael J Morris Susan F Slovin Yasutsuna Sasaki Shunji Takahashi Seiichiro Ozono Nga Kit Eliza Fung Shinta Cheng Jinping Gan Marco Gottardis Mary T Obermeier Jyotsna Reddy Steven Zhang Blisse J Vakkalagadda Leila Alland George Wilding Howard I Scher

Clin Cancer Res 2011 Feb 3;17(4):880-7. Epub 2010 Dec 3.

Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2955DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070382PMC
February 2011

NCCN Clinical Practice Guidelines Cancer-related fatigue.

Authors:
Ann M Berger Amy Pickar Abernethy Ashley Atkinson Andrea M Barsevick William S Breitbart David Cella Bernadine Cimprich Charles Cleeland Mario A Eisenberger Carmen P Escalante Paul B Jacobsen Phyllis Kaldor Jennifer A Ligibel Barbara A Murphy Tracey O'Connor William F Pirl Eve Rodler Hope S Rugo Jay Thomas Lynne I Wagner

J Natl Compr Canc Netw 2010 Aug;8(8):904-31

UNMC Eppley Cancer Center at The Nebraska Medical Center, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.6004/jnccn.2010.0067DOI Listing
August 2010

Novel targeted therapeutics for metastatic castration-resistant prostate cancer.

Authors:
Emmanuel S Antonarakis Michael A Carducci Mario A Eisenberger

Cancer Lett 2010 May 29;291(1):1-13. Epub 2009 Aug 29.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, United States.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.canlet.2009.08.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029098PMC
May 2010

LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy?

Authors:
Daniel Keizman Mario A Eisenberger

Oncology (Williston Park) 2009 Jun;23(7):631-2

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.

View Article

Download full-text PDF

 Source
June 2009

Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.

Authors:
Wennuan Liu Sari Laitinen Sofia Khan Mauno Vihinen Jeanne Kowalski Guoqiang Yu Li Chen Charles M Ewing Mario A Eisenberger Michael A Carducci William G Nelson Srinivasan Yegnasubramanian Jun Luo Yue Wang Jianfeng Xu William B Isaacs Tapio Visakorpi G Steven Bova

Nat Med 2009 May 12;15(5):559-65. Epub 2009 Apr 12.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/nm.1944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2839160PMC
May 2009

Treat early or wait? A stubborn question that remains unanswered.

Authors:
Mario A Eisenberger

Eur Urol 2009 Jan 7;55(1):23-5; discussion 26-7. Epub 2008 Oct 7.

View Article

Download full-text PDF

 Source
http://linkinghub.elsevier.com/retrieve/pii/S030228380801191
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2008.09.067DOI Listing
January 2009

Is abiraterone acetate well tolerated and effective in the treatment of castration-resistant prostate cancer?

Authors:
Emmanuel S Antonarakis Mario A Eisenberger

Nat Clin Pract Oncol 2009 Jan 28;6(1):12-3. Epub 2008 Oct 28.

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins School of Medicine, 1650 Orleans Street, Baltimore, MD 21231,USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/ncponc1262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014058PMC
January 2009

Bladder cancer.

Authors:
James E Montie Peter E Clark Mario A Eisenberger Rizk El-Galley Richard E Greenberg Harry W Herr Gary R Hudes Deborah A Kuban Timothy M Kuzel Paul H Lange Subodh M Lele Jeffrey Michalski Anthony Patterson Kamal S Pohar Jerome P Richie Wade J Sexton William U Shipley Eric J Small Donald L Trump Phillip J Walther Timothy G Wilson

J Natl Compr Canc Netw 2009 Jan;7(1):8-39

University of Michigan Comprehensive Cancer Center.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.6004/jnccn.2009.0002DOI Listing
January 2009

Words of wisdom. Re: Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. Attard G, Reide AHM, Yap TA, Raynaud F, Dowsett M, Settatree S, Barrett M, Parker C, Martins V, Folkerd E, Clark J, Cooper C, Kaye S, Dearnaley D, Lee G, de Bono JS. J Clin Oncol 2008;26:4563-71.

Authors:
Mario A Eisenberger

Eur Urol 2009 Jan;55(1):248

Johns Hopkins University-School of Medicine, Oncology Center, East Baltimore Campus, CRB 1M-Oncology, 1650 Orleans Street, Baltimore, MD 21231-1000, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.eururo.2008.09.035DOI Listing
January 2009

Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease.

Authors:
Thomas J Guzzo Craig G Rogers Chris Y Deng Trinity J Bivalacqua Ganesh S Palapattu Patrick J Bastian Mario A Eisenberger Mark P Schoenberg Mark L Gonzalgo

BJU Int 2008 Dec 22;102(11):1539-43. Epub 2008 Aug 22.

The Brady Urological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21287-2101, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/j.1464-410X.2008.07877.xDOI Listing
December 2008

Evolving new treatments for patients with prostate cancer: the advanced disease paradigm of the PSA era.

Authors:
Mario A Eisenberger

Urol Oncol 2008 Jul-Aug;26(4):406-7

Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.urolonc.2007.11.001DOI Listing
September 2008

Does short-term ADT before and during radiation therapy improve outcomes in locally advanced prostate cancer?

Authors:
Emmanuel S Antonarakis Mario A Eisenberger

Nat Clin Pract Urol 2008 Sep 29;5(9):480-1. Epub 2008 Jul 29.

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/ncpuro1175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036454PMC
September 2008

Phase II trial of docetaxel with rapid androgen cycling for progressive noncastrate prostate cancer.

Authors:
Dana Rathkopf Michael A Carducci Michael J Morris Susan F Slovin Mario A Eisenberger Roberto Pili Samuel R Denmeade Moshe Kelsen Tracy Curley Melinda Halter Connie Collins Martin Fleisher Glenn Heller Sharyn D Baker Howard I Scher

J Clin Oncol 2008 Jun;26(18):2959-65

Department of Medicine, Genitourinary Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2007.15.1928DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051836PMC
June 2008